4. Reasons to attend online:

1. Appreciate how to combine internal & external data with advanced technology, to develop RWE that provides value to KOLs, payers & regulators

2. Benchmark how technologies like AI, Big Data, Cloud, EDC, PROs, Mobile Apps or EHR can maximise the potential, evidence & insights from RWE

3. Learn how to turn big messy data, into structured evidence that provides insights and value.

4. Find out how industry leaders are collaborating with a myriad of diverse external stakeholders to generate robust, quality evidence 

Speakers List

INDUSTRY EXPERTS

Global Head, Medical Health Outcomes Research
Biogen

Chief Medical Officer & Head of Global Medical Affairs
Eisai

Associate Director of Healthcare Analytics, Health Economics & Market Access
Johnson & Johnson 

Senior Director, Real World Evidence and Medical Value, Medical Affairs at the Neurology Business GroupAffairs
Eisai

HTA Governance & Excellence - Global HEMA
Johnson & Johnson 

Senior Director, Value Evidence & Outcomes 
GSK

Real World Evidence Methods Lead EMEA
Janssen 

EMEA Medical Lead for Hematology Outcomes Network Europe 
Janssen 

 

Senior Adviser, Manager of Research and Development
The Norwegian Association for Pharma Industry (Legemiddelindustrien)

Director of Global Data Generation
Ionis Pharmaceuticals 

 

RWE & TECHNOLOGY EXPERTS

Founder & Chief Medical Officer 
Savana 

VP of AI Real World Evidence
Savana

Technical Lead, Life Sciences Research & Healthcare Solutions
Google Cloud

Guest Professor, Health Economic Evidence 
University of Ghent

Event Structure

Event Overview

REAL-WORLD SMART DATA: STRATEGY & PARTNERSHIPS

Day 1 - 26th October, 2021

REAL-WORLD BIG DATA & AI

Day 2 - 27th October, 2021

EVENT PARTNER

Related Videos

Presentation

AI-driven literature discovery provides critical context for interpreting registry information

Related topics: Medical Affairs & Stakeholder Engagement, Real-World Evidence & Late-Phase Research
Availability: FREE
Speakers

Jeffrey Saffer

CEO and Co-founder 
Quertle

Chahrazed Poignant

Business Development Manager
Karger

Gregor Bangert

Regional Manager
Karger

Presentation

Using RWD and machine Learning to drive patient identification in rare diseases

Related topics: Medical Affairs & Stakeholder Engagement, Real-World Evidence & Late-Phase Research
Availability: FREE
  • UK Data Sources and Access:
    • Hospital Episode Statistics
    • Primary care datasets – GPES, CPRD, OPCRD
  • Overview of key processes
  • Expanding the global reach
  • What the future could hold?
Speaker

Tony Cox

Development Director Real-World Evidence
OPEN Health

View Agenda or Register